Design

The decision problem or research question was whether vaccination against pertussis in pregnancy should be funded by the relevant public health care payer. To answer this question, we conducted a cost-utility analysis that compared pertussis vaccination to no vaccination. The analysis was conducted over a lifetime horizon from a health care payer perspective (incorporating the lifetime costs and effects of the vaccination and subsequent events). Our analysis corresponded with the 2017 Canadian guidelines for economic evaluation from the Canadian Agency for Drugs and Technologies in Health.¹⁸